Albireo Pharma Alpha and Beta Analysis
| ALBODelisted Stock | USD 44.15 0.75 1.67% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Albireo Pharma. It also helps investors analyze the systematic and unsystematic risks associated with investing in Albireo Pharma over a specified time horizon. Remember, high Albireo Pharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Albireo Pharma's market risk premium analysis include:
Beta 0.54 | Alpha 1.45 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Albireo |
Albireo Pharma Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Albireo Pharma market risk premium is the additional return an investor will receive from holding Albireo Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Albireo Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Albireo Pharma's performance over market.| α | 1.45 | β | 0.54 |
Albireo Pharma Fundamentals Vs Peers
Comparing Albireo Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Albireo Pharma's direct or indirect competition across all of the common fundamentals between Albireo Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Albireo Pharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Albireo Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Albireo Pharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Albireo Pharma to competition |
| Fundamentals | Albireo Pharma | Peer Average |
| Return On Equity | -0.93 | -0.31 |
| Return On Asset | -0.25 | -0.14 |
| Profit Margin | (2.29) % | (1.27) % |
| Operating Margin | (2.15) % | (5.51) % |
| Current Valuation | 259.98 M | 16.62 B |
| Shares Outstanding | 20.74 M | 571.82 M |
| Shares Owned By Insiders | 3.60 % | 10.09 % |
Albireo Pharma Opportunities
Albireo Pharma Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | International Biotechnology Trust PLC Makes New Investment in Albireo Pharma, Inc. | 02/01/2023 |
2 | SHAREHOLDER INVESTIGATION Halper Sadeh LLC Investigates TIG, ALBO, PAYA | 02/07/2023 |
3 | Biotech Went Through Its IPO Boom. Now the Shakeout Is Underway | 02/13/2023 |
4 | Ipsen extends expiration date of tender offer for Albireo Pharma, Inc. to 1 March 2023 | 02/22/2023 |
About Albireo Pharma Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Albireo or other delisted stocks. Alpha measures the amount that position in Albireo Pharma has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Albireo Pharma Upcoming Company Events
As portrayed in its financial statements, the presentation of Albireo Pharma's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Albireo Pharma's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Albireo Pharma's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Albireo Pharma. Please utilize our Beneish M Score to check the likelihood of Albireo Pharma's management manipulating its earnings.
| 7th of March 2023 Upcoming Quarterly Report | View | |
| 15th of May 2023 Next Financial Report | View | |
| 31st of December 2022 Next Fiscal Quarter End | View | |
| 7th of March 2023 Next Fiscal Year End | View | |
| 30th of September 2022 Last Quarter Report | View | |
| 31st of December 2021 Last Financial Announcement | View |
Build Portfolio with Albireo Pharma
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Albireo Pharma information on this page should be used as a complementary analysis to other Albireo Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Consideration for investing in Albireo Stock
If you are still planning to invest in Albireo Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Albireo Pharma's history and understand the potential risks before investing.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |